|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
| 1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option (right to buy) | $ 2.02 | (2) | 01/09/2024 | Common Stock, $0.001 par value per share | 150,000 | 150,000 | D | ||||||||
| Stock Option (right to buy) | $ 2.02 | (3) | 01/09/2024 | Common Stock, $0.001 par value per share | 30,000 | 30,000 | D | ||||||||
| Stock Option (right to buy) | $ 0.9 | (4) | 03/20/2023 | Common Stock, $0.001 par value per share | 100,000 | 100,000 | D | ||||||||
| Stock Option (right to buy) | $ 0.68 | (5) | 12/05/2022 | Common Stock, $0.001 par value per share | 125,000 | 125,000 | D | ||||||||
| Warrant (right to purchase Common Stock) | $ 0.4 | 05/24/2016 | X | 25,000 | 11/13/2012 | 11/13/2017 | Common Stock, $0.001 par value per share | 25,000 | $ 0 | 0 (6) | D | ||||
| Stock Option (right to buy) | $ 0.29 | (3) | 01/06/2022 | Common Stock, $0.001 par value per share | 5,000 | 5,000 (3) | D | ||||||||
| Stock Option (right to buy) | $ 0.28 | (7) | 11/21/2021 | Common Stock, $0.001 par value per share | 15,000 | 15,000 (7) | D | ||||||||
| Stock Option (right to buy) | $ 5.62 | (3) | 03/01/2025 | Common Stock, $0.001 par value per share | 50,000 | 50,000 | D | ||||||||
| Phantom Stock | $ 0 (8) | (8) | (8) | Common Stock, $0.001 par value per share | 594 | 594 | D | ||||||||
| Stock Option (right to buy) | $ 1.91 | (3) | 02/21/2026 | Common Stock, $0.001 par value per share | 75,000 | 75,000 | D | ||||||||
| Phantom Stock | $ 0 (8) | (8) | (8) | Common Stock, $0.001 par value per share | 1,653 | 1,653 | D | ||||||||
| Phantom Stock | $ 0 (8) | 05/13/2016 | A | 1,153 (9) | (8) | (8) | Common Stock, $0.001 par value per share | 1,153 | $ 0 | 1,153 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
| Duffy Matthew C/O CORMEDIX INC. 745 ROUTE 202-206, SUITE 303 BRIDGEWATER, NJ 08807 |
X | |||
| Alexander M. Donaldson, with a Power of Attorney for Matthew P. Duffy | 05/26/2016 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | Does not represent a sale in the market; represents the cashless exercise through the forfeiture of shares to the Issuer to pay the purchase price of the shares acquired upon conversion of the warrant. |
| (2) | These options vested 100% on January 10, 2014. |
| (3) | These options vest in full on the first anniversary of the date of grant. |
| (4) | These options vest quarterly over two years. |
| (5) | These options vest as follows: (a) fifty percent (50%) on the date of issuance of the CE Mark certification for Neutrolin in Europe, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013. |
| (6) | On November 13, 2012, the reporting person acquired in a private placement $10,000 of (a) 9% Senior Convertible Notes, convertible into shares of the Company's common stock at a conversion price of $0.35 per share, and (b) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share. |
| (7) | The options vest ratably, one-third of which will vest on each of the grant date, the first anniversary and the second anniversary thereof. |
| (8) | Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a directo |
| (9) | These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of director's fees. |